Shield by Guardant vs Freenome

Side-by-side comparison of cancer screening tests.

← Back to Cancer Screening

Shield by Guardant

FDA approved
$895

Colorectal only

Freenome

In development
Variable

Multiple

Test Performance

FeatureShield by GuardantFreenome
Price$895Variable
Cancers DetectedColorectal onlyMultiple
Sensitivity84% for CRCNot disclosed
Specificity90%Not disclosed
Sample TypeBlood drawBlood draw
FDA StatusFDA approvedIn development